echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Work with Eli Lilly!

    Work with Eli Lilly!

    • Last Update: 2021-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com





    On April 14, SciNeuro Pharmaceuticals announced that it had signed an exclusive license agreement with Eli Lilly and Company for development and commercialization in Greater China (including Mainland China, Hong Kong, Macau and Taiwan) This is a targeted therapy called "α-synuclein" (α-synuclein).

    Saishen Medicine focuses on the field of central nervous system diseases.


    In December 2020, it announced that it officially set sail and completed a US$100 million Series A financing.
    The founder and CEO is Dr.
    Limin.


    In this cooperation with Eli Lilly, Celestine Pharma has obtained the exclusive license to develop Eli Lilly’s α-synuclein-targeted antibody in the Greater China region.


    How does alpha-synuclein affect neurological diseases? According to reports in the literature, in the brains of many patients with neurodegenerative diseases, some proteins will aggregate to form chain-like amyloid fibril (amyloid fibril).


    Source: 123RF

    “There are currently about 3 million elderly people in Greater China affected by Parkinson’s disease, causing a huge disease burden.


    Dr.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.